ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

New for Upcoming MedTech Conference: AdvaMed Announces Investor Forum, Including Session With Chief Executives for Corporate Purpose

By: 3BL Media

SOURCE: CECP: Chief Executives for Corporate Purpose

DESCRIPTION:

WASHINGTON, May 17, 2022 /3BL Media/ - The Advanced Medical Technology Association (AdvaMed), the world’s largest trade organization representing medical technology device developers and manufacturers, today announced the first-ever Investor Forum at The MedTech Conference in October. The Investor Forum will feature special programs, including a flagship session called the Chief Executives for Corporate Purpose (CECP) CEO Investor Forum @ The MedTech Conference, where leading medtech CEOs will share insights on the sustained value of medtech for investors. Conference attendees will be able to attend regular programming, often relevant to investors, in addition to the investor-focused sessions.

“AdvaMed is always looking to increase value to our members and The MedTech Conference attendees,” said Scott Whitaker, AdvaMed president and CEO. “Expanding our investment programming at the conference makes sense in a lot of ways. Medtech companies range from the smallest startups to companies that are household names. Investment often plays a key role at every stage of development. On the investor side, medtech companies offer value for investors of all kinds. Our companies serve the core needs of society, with technology that saves and improves lives. Bringing medtech developers and investors together will help our industry create even more innovative products to serve patients.”

Investor Forum programming will include reverse pitch presentations featuring corporate and business development executives and investors; one-on-one partnering, where companies and investors will be able to evaluate fresh investment opportunities, from startups to emerging growth companies; sessions covering topics such as mergers and acquisitions, early- and growth-stage funding, the supply chain, and the latest on regulatory and reimbursement issues; presentations from the top 50 early and mid-stage companies in the 2022 MedTech Innovator program; and the day-long CECP’s CEO Investor Forum @ The MedTech Conference, where leading medtech CEOs will share their companies’ Long-Term Plans for sustainable value creation with investors. EY is a presenting sponsor of the CECP CEO Investor Forum @ The MedTech Conference.

“This 10th CEO Investor Forum, co-hosted by CECP and AdvaMed, will provide an opportunity for leading medtech companies to share their sustainable business long-term plans to those assembled and a global online audience,” said Daryl Brewster, CEO, Chief Executives for Corporate Purpose. “Companies will share their integrated plans. Investors will gain more insight about how companies drive long-term value. And, unlike so much investor communication, the focus will be on investing in and driving sustainable value creation across their stakeholders, not just short-term gains."

Development of the Investor Forum at The MedTech Conference is being guided by a committee of medtech industry leaders and investors.

“Medical device technology improves the quality of life for countless patients,” said Darshana Zaveri, founder and managing partner of Catalyst Health Ventures, who is participating in the Investor Forum committee. “As a Bostonian, I’m delighted The Medtech Conference will launch its new investor content in Boston. Our city has a tremendous medtech presence, from startups to established companies, and a positive environment for investors to learn more about the medtech products in development or already serving patients in Boston and beyond.”

Each fall, AdvaMed convenes The MedTech Conference as the foremost gathering of medical technology professionals in North America. The MedTech Conference this year takes place October 24-26 in person in Boston.

The MedTech Conference will include its traditional slate of world-class speakers and cross-cutting educational programming in addition to the Investor Forum. Register here.

CECP Media Contact:
Katie Leasor
kleasor@cecp.co

# # #

About AdvaMed
AdvaMed member companies produce the medical devices, diagnostic products and health information systems that are transforming health care through earlier disease detection, less invasive procedures, and more effective treatments. AdvaMed members range from the largest to the smallest medical technology innovators and companies. For more information, visit www.advamed.org.

About Chief Executives for Corporate Purpose (CECP)
Chief Executives for Corporate Purpose® (CECP) is a trusted advisor to companies on their corporate purpose journeys to build long-term sustainable value and tell their impact stories. CECP is a movement of more than 200 of the world’s largest companies that represent $11.2 trillion in revenues, $23 billion in total community investment, 14 million employees, 30 million hours of employee engagement, and $21 trillion in assets under management. For more information, visit http://cecp.co.

Tweet me: .@AdvaMedEvents, @CECPtweets, @EYnews announced the first-ever Investor Forum at The #MEDTECH Conference in Oct to share insights on the sustained value of medtech for investors. Learn more: https://bit.ly/3FNGnVv

KEYWORDS: healthy communities, corporate purpose, CECP

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.